Inhaled human insulin: Coup or caution?

Cleveland Clinic Journal of Medicine

Volumn 73, Issue 6, 2006, Pages 580-582

  Stoller, James K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

ASTHMA; CANCER INCIDENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; FOOD AND DRUG ADMINISTRATION; FORCED EXPIRATORY VOLUME; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL LUNG DISEASE; LUNG CANCER; LUNG DISEASE; LUNG FUNCTION TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PREDICTION; PRESCRIPTION; QUALITY CONTROL; SMOKING; SPIROMETRY; STAFF TRAINING; STATISTICAL SIGNIFICANCE; SURVIVAL;

ADMINISTRATION, INHALATION; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; TREATMENT OUTCOME;

EID: 33745078011     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.73.6.580     Document Type: Editorial

References (12)

1. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis [letter]. The Pulmozyme Study Group. N Engl J Med 1994; 331:637-642.
2. Spencer LT, Humphries JE, Brantly ML. Transgenic Human Alpha-1 Antitrypsin Study Group. Antibody response to aerosolized transgenic human alpha-1 antitrypsin. [letter] N Engl J Med 2005; 352:2030-2031
3. Davidson MB, Mehta AE, Siraj ES. Inhaled human insulin: an inspiration for patients with diabetes mellitus? Cleve Clin J Med 2006; 73:569-578.
4. Food and Drug Administration proceedings. www.fda.gov/ohrms/dockets/ac/ cder05.html#EndocrinologicMetabolic.
5. Medication guide, Exubera. www.fda.gov. Accessed May 17, 2006.
6. Gupta K, Krishnaswamy G, Karnad A, Peiris AN. Insulin: a novel factor in carcinogenesis. Am J Med Sci 2002; 323:140-145.
7. American Thoracic Society. Standards for the diagnosis and management of patients with COPD. www-test.thoracic.org/copd. Accessed February 21, 2006
8. Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999; 116:416-423.
9. Corrigan SP, Cecillon DL, Sin DD, et al. The costs of implementing the 1999 Canadian Asthma Consensus Guidelines recommendation of asthma education and spirometry for the family physician. Can Respir J 2004; 11:349-353.
10. Buffels J, Degryse J, Heyrman J, Decramer M; DIDASCO Study. Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest 2004; 125:1394-1399.
11. Enright PL., Linn WS, Avol EL, Margolis HIS, Gong H Jr, Peters JM. Quality of spirometry test performance in children and adolescents: experience in a large field study. Chest 2000; 118:665-671.
12. Stoller JK, Buist AS, Burrows B, et al. Quality control of spirometry testing in the registry for patients with severe alpha-1 antitrypsin deficiency. Alpha-1 Antitrypsin Deficiency Registry Study Group. Chest 1997; 111:899-909.